These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24630976)

  • 1. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism.
    Mulatero P; Monticone S; Bertello C; Viola A; Tizzani D; Iannaccone A; Crudo V; Burrello J; Milan A; Rabbia F; Veglio F
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4826-33. PubMed ID: 24057288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.
    Zhang SL; Gao JW; Guo Y; Feng QL; Tang JY; Yan L; Wang JF; Cheng H; Liu PM
    Front Endocrinol (Lausanne); 2020; 11():547356. PubMed ID: 33101195
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants.
    Ronconi V; Turchi F; Rilli S; Di Mattia D; Agostinelli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):93-100. PubMed ID: 19481913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.
    Savard S; Amar L; Plouin PF; Steichen O
    Hypertension; 2013 Aug; 62(2):331-6. PubMed ID: 23753408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].
    Deng YJ; Zhang SL; Liu PM; Mai LF; Tang JY; Yan L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):743-749. PubMed ID: 27667270
    [No Abstract]   [Full Text] [Related]  

  • 8. Adipokines and cardiometabolic profile in primary hyperaldosteronism.
    Iacobellis G; Petramala L; Cotesta D; Pergolini M; Zinnamosca L; Cianci R; De Toma G; Sciomer S; Letizia C
    J Clin Endocrinol Metab; 2010 May; 95(5):2391-8. PubMed ID: 20194710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure, thyroid-stimulating hormone, and thyroid disease prevalence in primary aldosteronism and essential hypertension.
    Turchi F; Ronconi V; di Tizio V; Boscaro M; Giacchetti G
    Am J Hypertens; 2011 Dec; 24(12):1274-9. PubMed ID: 21850059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism.
    Wu Q; Hong M; Xu J; Tang X; Zhu L; Gao P; Wang J
    Endocrine; 2021 Jun; 72(3):835-843. PubMed ID: 33474712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
    Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
    J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study.
    Napoli C; Di Gregorio F; Leccese M; Abete P; Ambrosio G; Giusti R; Casini A; Ferrara N; De Matteis C; Sibilio G; Donzelli R; Montemarano A; Mazzeo C; Rengo F; Mansi L; Liguori A
    J Investig Med; 1999 May; 47(5):212-21. PubMed ID: 10361380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between thyroid function, thyroid diseases, and primary aldosteronism.
    Maiturouzi M; Zhu Q; Zhang D; Luo Q; Wang M; Cai X; Heizhati M; Cai L; Wu T; Liu S; Dang Y; Aimudula A; Hong J; Li N
    Eur J Endocrinol; 2024 Aug; 191(2):262-270. PubMed ID: 39166829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone health and aldosterone excess.
    Ceccoli L; Ronconi V; Giovannini L; Marcheggiani M; Turchi F; Boscaro M; Giacchetti G
    Osteoporos Int; 2013 Nov; 24(11):2801-7. PubMed ID: 23695421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
    Pan CT; Wu XM; Tsai CH; Chang YY; Chen ZW; Chang CC; Lee BC; Liao CW; Chen YL; Lin LC; Chang YR; Hung CS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():646097. PubMed ID: 33953695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.